(Source: InspireMD Inc) BOSTON, MA - March 21, 2016 - InspireMD, Inc. ('InspireMD' or the 'Company') (NYSE MKT: NSPR), a leader in embolic protection systems ('EPS'), today announced the closing of its private placement of 1,033,051 shares of its common stock and warrants to purchase up to 516,526 shares of common stock to certain of the Company's officers and directors (the 'Private Placement'). The common stock was sold at a price of $0.59 per share, and each purchaser received a warrant to purchase one half of one share of common stock for each share of common stock that it purchased. The warrants are exercisable immediately and have a term of exercise of five years from the date of...
↧
InspireMD Announces Closing of Private Placement to Certain Officers and Directors (InspireMD Inc)
↧